According to BioIntel360, the United States biosimilar market size is expected to record a CAGR of 30.7% during 2023-2027 to reach US$11,316.0 million by 2027, increasing from US$3,879.6 million in 20...
According to BioIntel360, the United States biosimilar market size is expected to record a CAGR of 30.7% during 2023-2027 to reach US$11,316.0 million by 2027, increasing from US$3,879.6 million in 2023. Over the last five years, the sector has recorded a CAGR of 30.5%. This report provides an in-depth data-centric analysis of the emerging opportunities in the biosimilars industry. It covers a detailed view of market size and forecast across various segments such as by product, type of cell, imaging technique, procedure, source of manufacturing, applications, type of technology, and end users. This section is a part of the title “Global Biosimilars Business and Investment Opportunities – Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, and Competitive Landscape – Q1 2023 Update”.
This report provides an in-depth, data-centric analysis of the United States biosimilar market 2018-2027. Below is a summary of key market segments: Biosimilar Market Size By Product • Monoclonal Antibody Biosimilars • Insulin Biosimilar • Biosimilar Interferons • Other Biosimilar Biosimilar Market Size By Type of Cell • Mammalian • Non-Mammalian Biosimilar Market Size By Imaging Technique • Magnetic Resonance Imaging Scanners • Computed Tomography Scanners • Positron Emission Tomography Scanners • Others Biosimilar Market Size By Procedure • Invasive • Non-Invasive Biosimilar Market Size By Source of Manufacturing • In-House • Contract Manufacturing Biosimilar Market Size By Applications • Oncology • Blood Disorders • Growth Hormonal Deficiency • Chronic & Autoimmune Disorders • Infectious Diseases • Others Biosimilar Market Size By Type of Technology • Mass Spectroscopy • Chromatography • Recombinant DNA technology • Electrophoresis • Others Biosimilar Market Size By End User • Hospital & Clinics • Diagnostic Centres • Others
• In-depth understanding of biosimilars market dynamics: Understand market opportunity, industry dynamics, key trends and drivers across different market segments and sub-segments of the industry in United States. • Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry. • Get market share analysis by end users: Get a detailed analysis across different end users such as hospitals & clinics, diagnostic centres within the United States.
1 United States Biosimilar Market Size and Forecast, 2018-2027 2 United States Biosimilar Market Share by Product, 2018-2027 2.1 Biosimilar Market Size by Monoclonal Antibody Biosimilars, 2018-2027 2.2 Biosimilar Market Size by Insulin Biosimilar, 2018-2027 2.3 Biosimilar Market Size by Biosimilar Interferons, 2018-2027 2.4 Biosimilar Market Size by Other Biosimilars, 2018-2027 3 United States Biosimilar Market Share by Monoclonal Antibody Biosimilars, 2018-2027 4 United States Biosimilar Market Share by Insulin Biosimilars, 2018-2027 5 United States Biosimilar Market Share by Interferons Biosimilars, 2018-2027 6 United States Biosimilar Market Share by Other Biosimilars, 2018-2027 7 United States Biosimilar Market Share by Type of Cell, 2018-2027 7.1 Biosimilar Market Size by Mammalian Cell, 2018-2027 7.2 Biosimilar Market Size by Non-Mammalian Cell, 2018-2027 8 United States Biosimilar Market Share by Imaging Technique, 2018-2027 8.1 Biosimilar Market Size by Magnetic Resonance Imaging Scanners, 2018-2027 8.2 Biosimilar Market Size by Computed Tomography Scanners, 2018-2027 8.3 Biosimilar Market Size by Positron Emission Tomography Scanners, 2018-2027 8.4 Biosimilar Market Size by Others, 2018-2027 9 United States Biosimilar Market Share by Procedure, 2018-2027 9.1 Biosimilar Market Size by Invasive Procedure, 2018-2027 9.2 Biosimilar Market Size by Non-Invasive Procedure, 2018-2027 10 United States Biosimilar Market Share by Source of Manufacturing, 2018-2027 10.1 Biosimilar Market Size by In-House, 2018-2027 10.2 Biosimilar Market Size by Contract Manufacturing, 2018-2027 11 United States Biosimilar Market Share by Applications, 2018-2027 11.1 Biosimilar Market Size by Oncology, 2018-2027 11.2 Biosimilar Market Size by Blood Disorders, 2018-2027 11.3 Biosimilar Market Size by Growth Hormonal Deficiency, 2018-2027 11.4 Biosimilar Market Size by Chronic & Autoimmune Disorders, 2018-2027 11.5 Biosimilar Market Size by Infectious Diseases, 2018-2027 11.6 Biosimilar Market Size by Others, 2018-2027 12 United States Biosimilar Market Share by Type of Technology, 2018-2027 12.1 Biosimilar Market Size by Mass Spectroscopy, 2018-2027 12.2 Biosimilar Market Size by Chromatography, 2018-2027 12.3 Biosimilar Market Size by Recombinant DNA Technology, 2018-2027 12.4 Biosimilar Market Size by Electrophoresis, 2018-2027 12.5 Biosimilar Market Size by Others, 2018-2027 13 United States Biosimilar Market Share by End User, 2018-2027 13.1 Biosimilar Market Size by Hospital & Clinics, 2018-2027 13.2 Biosimilar Market Size by Diagnostic Centres, 2018-2027 13.3 Biosimilar Market Size by Others, 2018-2027
Table 1: United States Biosimilar Market Size by Value (USD MM) 2018-2027 Table 2: United States Biosimilar Market Size by Monoclonal Antibody Biosimilars, by Value (USD MM), 2018-2027 Table 3: United States Biosimilar Market Size by Insulin Biosimilar, by Value (USD MM) 2018-2027 Table 4: United States Biosimilar Market Size by Biosimilar Interferons, by Value (USD MM) 2018-2027 Table 5: United States Biosimilar Market Size by Other Biosimilars, by Value (USD MM) 2018-2027 Table 6: United States Biosimilar Market Size by Mammalian Cell, by Value (UDS MM) 2018-2027 Table 7: United States Biosimilar Market Size by Non-Mammalian Cell, by Value (UDS MM) 2018-2027 Table 8: United States Biosimilar Market Size by Magnetic Resonance Imaging Scanners, by Value (USD MM), 2018-2027 Table 9: United States Biosimilar Market Size by Computed Tomography Scanners, by Value (USD MM), 2018-2027 Table 10: United States Biosimilar Market Size by Positron Emission Tomography Scanners, by Value (USD MM), 2018-2027 Table 11: United States Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 Table 12: United States Biosimilar Market Size by Invasive Procedure (USD MM), 2018-2027 Table 13: United States Biosimilar Market Size by Non-Invasive Procedure (USD MM), 2018-2027 Table 14: United States Biosimilar Market Size by In-House, by Value (USD MM), 2018-2027 Table 15: United States Biosimilar Market Size by Contract Manufacturing, by Value (USD MM), 2018-2027 Table 16: United States Biosimilar Market Size by Oncology, by Value (USD MM), 2018-2027 Table 17: United States Biosimilar Market Size by Blood Disorders, by Value (USD MM), 2018-2027 Table 18: United States Biosimilar Market Size by Growth Hormonal Deficiency, by Value (USD MM), 2018-2027 Table 19: United States Biosimilar Market Size by Chronic & Autoimmune Disorders, by Value (USD MM), 2018-2027 Table 20: United States Biosimilar Market Size by Infectious Diseases, by Value (USD MM), 2018-2027 Table 21: United States Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 Table 22: United States Biosimilar Market Size by Mass Spectroscopy, by Value (USD MM), 2018-2027 Table 23: United States Biosimilar Market Size by Chromatography, by Value (USD MM), 2018-2027 Table 24: United States Biosimilar Market Size by Recombinant DNA Technology, by Value (USD MM), 2018-2027 Table 25: United States Biosimilar Market Size by Electrophoresis, by Value (USD MM), 2018-2027 Table 26: United States Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 Table 27: United States Biosimilar Market Size by Hospital & Clinics, by Value (USD MM), 2018-2027 Table 28: United States Biosimilar Market Size by Diagnostic Centres, by Value (USD MM), 2018-2027 Table 29: United States Biosimilar Market Size by Others, by Value (USD MM), 2018-2027
Figure 1: United States Biosimilar Market Size by Value (USD MM) 2018-2027 Figure 2: United States Biosimilar Market Share by Product (%), 2018-2027 Figure 3: United States Biosimilar Market Size by Monoclonal Antibody Biosimilars, by Value (USD MM), 2018-2027 Figure 4: United States Biosimilar Market Size by Insulin Biosimilar, by Value (USD MM) 2018-2027 Figure 5: United States Biosimilar Market Size by Biosimilar Interferons, by Value (USD MM) 2018-2027 Figure 6: United States Biosimilar Market Size by Other Biosimilars, by Value (USD MM) 2018-2027 Figure 7: United States Biosimilar Market Share Monoclonal Antibody Biosimilars (%), 2018-2027 Figure 8: United States Biosimilar Market Share by Insulin Biosimilars (%), 2018-2027 Figure 9: United States Biosimilar Market Share by Interferons Biosimilars (%), 2018-2027 Figure 10: United States Biosimilar Market Share by Other Biosimilars (%), 2018-2027 Figure 11: United States Biosimilar Market Share by Type of Cell (%), 2018-2027 Figure 12: United States Biosimilar Market Share by Mammalian Cell, by Value (UDS MM) 2018-2027 Figure 13: United States Biosimilar Market Share by Non-Mammalian Cell, by Value (UDS MM) 2018-2027 Figure 14: United States Biosimilar Market Share by Imaging Technique (%), 2018-2027 Figure 15: United States Biosimilar Market Size by Magnetic Resonance Imaging Scanners, by Value (USD MM), 2018-2027 Figure 16: United States Biosimilar Market Size by Computed Tomography Scanners, by Value (USD MM), 2018-2027 Figure 17: United States Biosimilar Market Size by Positron Emission Tomography Scanners, by Value (USD MM), 2018-2027 Figure 18: United States Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 Figure 19: United States Biosimilar Market Share by Procedure (%), 2018-2027 Figure 20: United States Biosimilar Market Size by Invasive Procedure (USD MM), 2018-2027 Figure 21: United States Biosimilar Market Size by Non-Invasive Procedure (USD MM), 2018-2027 Figure 22: United States Biosimilar Market Share by Source of Manufacturing (%), 2018-2027 Figure 23: United States Biosimilar Market Size by In-House, by Value (USD MM), 2018-2027 Figure 24: United States Biosimilar Market Size by Contract Manufacturing, by Value (USD MM), 2018-2027 Figure 25: United States Biosimilar Market Share by Applications (%), 2018-2027 Figure 26: United States Biosimilar Market Size by Oncology, by Value (USD MM), 2018-2027 Figure 27: United States Biosimilar Market Size by Blood Disorders, by Value (USD MM), 2018-2027 Figure 28: United States Biosimilar Market Size by Growth Hormonal Deficiency, by Value (USD MM), 2018-2027 Figure 29: United States Biosimilar Market Size by Chronic & Autoimmune Disorders, by Value (USD MM), 2018-2027 Figure 30: United States Biosimilar Market Size by Infectious Diseases, by Value (USD MM), 2018-2027 Figure 31: United States Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 Figure 32: United States Biosimilar Market Share by Type of Technology (%), 2018-2027 Figure 33: United States Biosimilar Market Size by Mass Spectroscopy, by Value (USD MM), 2018-2027 Figure 34: United States Biosimilar Market Size by Chromatography, by Value (USD MM), 2018-2027 Figure 35: United States Biosimilar Market Size by Recombinant DNA Technology, by Value (USD MM), 2018-2027 Figure 36: United States Biosimilar Market Size by Electrophoresis, by Value (USD MM), 2018-2027 Figure 37: United States Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 Figure 38: United States Biosimilar Market Share by End User (%), 2018-2027 Figure 39: United States Biosimilar Market Size by Hospital & Clinics, by Value (USD MM), 2018-2027 Figure 40: United States Biosimilar Market Size by Diagnostic Centres, by Value (USD MM), 2018-2027 Figure 41: United States Biosimilar Market Size by Others, by Value (USD MM), 2018-2027
